Tonix Pharmaceuticals Holding Corp.

( )
TNXP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
AMRNAmarin Corporation Plc Sponsored ADR
SAGESAGE Therapeutics, Inc.
PRGOPerrigo Co. Plc
JAZZJazz Pharmaceuticals Plc
GWPHGW Pharmaceuticals PLC Sponsored ADR
PTLAPortola Pharmaceuticals, Inc.
ICPTIntercept Pharmaceuticals, Inc.
AXSMAxsome Therapeutics, Inc.
MNKMallinckrodt Plc
CTLTCatalent Inc
UTHRUnited Therapeutics Corporation
ENDPEndo International Plc
HZNPHorizon Pharma plc
PCRXPacira Pharmaceuticals, Inc.

Company Profile

Tonix Pharmaceuticals Holding Corp. operates as a clinical-stage pharmaceutical company, which engages in the development of pharmaceutical products for public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It offers TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.